These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 17136954)

  • 1. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design.
    Buist AS; Vollmer WM; Sullivan SD; Weiss KB; Lee TA; Menezes AM; Crapo RO; Jensen RL; Burney PG
    COPD; 2005 Jun; 2(2):277-83. PubMed ID: 17136954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative.
    Buist AS; Vollmer WM; McBurnie MA
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):703-8. PubMed ID: 18544191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the methodology regarding the prevalence survey of chronic obstructive pulmonary disease in China].
    Zhou YM; Liu SM; Lv JC; Zheng JP; Zhong NS; Ran PX
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):814-8. PubMed ID: 17299971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norwegian population surveys on respiratory health in adults: objectives, design, methods, quality controls and response rates.
    Gulsvik A; Humerfelt S; Bakke PS; Omenaas ER; Lehmann S
    Clin Respir J; 2008 Oct; 2 Suppl 1():10-25. PubMed ID: 20298346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
    Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
    Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COPD: Burden, risk factors and prevalence].
    Karpinski NA; Petermann F
    Gesundheitswesen; 2009 Dec; 71(12):816-22. PubMed ID: 19621281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of COPD in Iceland--the BOLD study].
    Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
    Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea.
    Kim SJ; Suk MH; Choi HM; Kimm KC; Jung KH; Lee SY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1393-8. PubMed ID: 17167958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.
    Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P
    Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economics of COPD: literature review and experiences from field work.
    Nielsen R; Klemmetsby M; Gulsvik A
    Clin Respir J; 2008 Oct; 2 Suppl 1():104-10. PubMed ID: 20298358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD: a prevalence estimation model.
    Peabody JW; Schau B; Lopez-Vidriero M; Vestbo J; Wade S; Iqbal A
    Respirology; 2005 Nov; 10(5):594-602. PubMed ID: 16268912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The importance of chronic obstructive pulmonary disease].
    Vondra V
    Vnitr Lek; 2004 Sep; 50(9):654-8. PubMed ID: 15580895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide burden of COPD in high- and low-income countries. Part II. Burden of chronic obstructive lung disease in Latin America: the PLATINO study.
    Menezes AM; Perez-Padilla R; Hallal PC; Jardim JR; Muiño A; Lopez MV; Valdivia G; Pertuze J; Montes de Oca M; Tálamo C;
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):709-12. PubMed ID: 18544192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of smoking-related disease in Thailand: a prevalence-based analysis.
    Leartsakulpanitch J; Nganthavee W; Salole E
    J Med Assoc Thai; 2007 Sep; 90(9):1925-9. PubMed ID: 17957939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of chronic obstructive pulmonary disease and its effects on managed care.
    Mapel D; Chen JC; George D; Halbert RJ
    Manag Care Interface; 2004 Apr; 17(4):61-6. PubMed ID: 15108761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeatability of health economic data in COPD.
    Nielsen R; Johannessen A; Schnelle HM; Bakke PS; Askildsen JE; Omenaas ER; Gulsvik A
    Respir Med; 2008 Nov; 102(11):1556-62. PubMed ID: 18674894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Walk-in spirometry pilot project for discovering of early chronic obstructive pulmonary disease].
    Løkke A; Christensen LB; Fuglsang C
    Ugeskr Laeger; 2009 Oct; 171(43):3083-8. PubMed ID: 19852895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.